© Copyright Nostre Net
The well-established global onychomycosis market is growing pervasively. Rising prevalence of onychomycosis and per capita healthcare expenditure worldwide are the major driving forces behind the growth of the market. Besides, factors such as the surge in the diabetic patient population and the increasing occurrences of peripheral artery disease (PAD) impact the market growth positively.
Market Research Future (MRFR), in its recently published onychomycosis market trends, asserts that the market is estimated to rise to USD 7,912.5 MN by 2025. MRFR also mentions that this appreciation of the market value would be registered at 6.28% CAGR during the assessment period (2019-2025). The availability of therapeutic medicines is blowing up the market size, providing growth opportunities to the market players.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1340
Major Players:
Some of the eminent leaders in the global Onychomycosis market include Pfizer, Inc. (the US), Novartis AG (Switzerland), Galderma Laboratories (Switzerland), Moberg Pharma AB (Sweden), Bausch Health Sciences (Canada), Dr. Reddy's Laboratories Ltd (India), Merz Pharma (Germany), Medimetriks Pharmaceuticals, Inc. (US), Kaken Pharmaceutical Co., Ltd. (Japan), GlaxoSmithKline plc (UK), Taro Pharmaceuticals Industries Ltd. (Israel), and Johnson & Johnson Services, Inc. (US), among others.
Drivers & Restraints:
Some of the other major factors substantiating the market growth include improving economic conditions worldwide that enable access to quality and improved healthcare. Also, the changing or unhealthy lifestyle and pollution that is led by the growing urbanization & industrialization propel the growth of the onychomycosis treatment market globally. Additionally, technological advancements, backed by the substantial investments made in the R&D activities, foster the market growth excellently.
On the other hand, the lack of awareness about onychomycosis, alongside the availability of treatments, is projected to inhibit the market growth over the anticipated period. Also, factors such as unmet clinical needs, side-effects associated with onychomycosis treatment medicines, drug resistance, and complications occurring during the treatment are expected to impede the market growth during the review period.
Global Onychomycosis Market - Segments
By Type : Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, and others.
By Treatment Type : Drug Treatment, Topical Therapy, and others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and others.
By Regions : Europe, North America, APAC, and Rest-of-the-World.
Global Onychomycosis Market - Regional analysis
North America holds the largest share in the global onychomycosis market. The market growth attributes to the increasing number of patients suffering from immune diseases and the presence of a huge geriatric population. Also, the increasing prevalence of onychomycosis and peripheral artery disease acts as a major driving force for the market growth. Besides, factors such as the presence of key market participants, sophisticated healthcare infrastructure, and rising per capita healthcare expenditure contribute to the regional market growth significantly.
Europe stands second in the global onychomycosis market. The onychomycosis market size in the region is majorly growing due to the rising geriatric population and the increasing burden of diabetes and growing occurrence rates of onychomycosis. Also, flourishing pharmaceutical industries in European countries such as the UK, Germany, France, and Spain, significantly contribute to the onychomycosis treatment market in the region.
Furthermore, factors such as the rising per capita income and strong healthcare penetration, and the availability of advanced treatment facilities & skilled medical professionals drive the growth of the regional market at a large scale. Also, the government support for research & development plays a major role in the development of European onychomycosis markets.
Asia Pacific has emerged as a rapidly progressing market for onychomycosis due to the rising prevalence of various skin infections. Markets in China and India backed by the vast population and the availability of low-cost medications to treat Onychomycosis treatment foster the market growth in the region. Moreover, the rapidly growing healthcare sectors, coupled with the large unmet needs, provide impetus to the market growth.
Global Onychomycosis Market - Competitive Analysis
Highly competitive, the global onychomycosis market appears to be fragmented due to the presence of a large number of players. The increase of spurious and counterfeit medicines has opened doors for new drug development and opportunities for a new market leader. To gain a larger competitive advantage, these players incorporate strategies such as mergers & acquisitions, expansions, collaborations, and product/technology launch.
Access full report @ https://www.marketresearchfuture.com/reports/onychomycosis-market-1340
Get More Related Report
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The diversification of healthcare facilities has been motivated by the expansion in the market size and growing demand for medical services. Market reports connected with healthcare industry have been offered by Market Research Future which creates reports on other industry verticals that intends to analyze the current market scenarios better. The market is set to achieve revenues valued at USD 270 billion while achieving a CAGR of 12.9% in the duration of the forecast period.
The e-health services market size is benefitted by the presence of a robust information and telecommunication sector, which has led to a significant development in the market. The current technological developments in the market are fuelled by the widespread use of software in healthcare and the need to reduce cost and improve efficiencies. Moreover, the market for e-health services is expected to be encouraged by the rising implementation of e-health software in medical facilities globally.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1252
Competitive Analysis
The present execution of strategies is assumed to motivate the market in the approaching years. The development of a strong value chain is moreover motivating the expansion of the market. The vertical additions and product tactics of the market are boosting the potential of the market firms. Significant cutbacks in administrative budgets are bringing further development of the market. The augmented conformity of market players to new clients and market trend tendencies are improving the growth curve of the market and will continue in the forecast period. The calculated goals envisioned for the market are buoyed due to beneficial product differentiation supported by market competitors. The development of the market is moving in a promising direction due to original product launches or intensifying gross revenue of the players in the market.
The competitors functioning in the market for e-health services are Allscripts Healthcare Solutions Inc. (U.S), GE Healthcare (U.S), Boston Scientific Corp (U.S), McKinsey & Co. (U.S), Apple (U.S), Motion Computing Inc. (U.S), Epocrates Inc. (U.S), Telecare Corp. (U.S), IBM Corporation (U.S), Proteus Digital Health (U.S) GE Healthcare (U.S) and Cerner (U.S).
Segmental Analysis
The segmentation of the e-health services market is carried out on the basis of type, region, and service. Based on type, the e-health service market comprises of segments such as ePrescribing, Electronic Health Records (EHR), big data systems, Telemedicine, Clinical Decision Support System (CDSS), Knowledge Management System (KMS) and Consumer health IT. Based on service, the market for e-health services is segmented into clinical services, financial services, and administrative services. The end user segment of the e-health service market comprises of clinics, hospitals, health insurance companies, and others. The regions encompassed in the e-health services market are Europe, Asia Pacific, Americas, and the Middle East and Africa.
Detailed Regional Analysis
The regional analysis of the e-health services market comprises of regions such as Europe, the Americas, Asia Pacific, Middle East, and Africa. The North American region is the principal market for the e-health services market which is driven by countries such as the US. The presence of top companies and the extensive implementation of software for data management in the market is boosting the progress of the market. The European region is observed as the next chief region in the e-health services market. The Asia Pacific region is showing the most rapid growth in this e-health services market. While the e-health services market in the Middle East and Africa is estimated to display steady growth in the duration of the forecast period.
Browse More Report:
Access full report @ https://www.marketresearchfuture.com/reports/e-health-services-market-1252
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
North America to Dominate Global Organic and Natural Tampons Market
The global organic and natural
tampons market is expected to exhibit a solid 8.67% CAGR over the forecast
period from 2018 to 2023, according to the latest research report from Market
Research Future (MRFR). The organic and natural tampons was valued at USD 590.6
million in 2017 and is likely to exhibit steady, stable growth over the
forecast period.
Organic and natural tampons are
becoming widely popular due to the growing demand for natural products in the
feminine hygiene sector and the growing product diversification in the field of
feminine hygiene products. Due to the growing demand from the demographic of
working women, feminine hygiene product manufacturers are looking to provide a
widespread choice to their female consumers in terms of product configuration.
This has become a major driver for the organic
and natural tampons market manufacture due to the growing demand for
organic and natural products in the healthcare sector. The rising demand for
organic and natural products is mainly driven by the increasing perception that
organic and natural products are better for the consumer than conventional
artificial products. This is likely to be a major driver for the global organic
and natural tampons market over the forecast period.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/7232
Competitive Leaderboard:
Leading players in the global
organic and natural tampons market include NutraMarks, TOM Organic, Maxim
Hygiene, The Honest Company, Seventh Generation, BON, ALYK, Bodywise, and
Procter & Gamble. Leading players in the global organic and natural tampons
market are likely to focus on product capacity expansion and product
diversification over the coming years, as the demand for various types of
tampons is likely to grow over the forecast period.
Segmentation:
The global organic and natural
tampons market has been segmented into type, size, odor type, and region.
Based on type, the organic and
natural tampons market is segmented into cardboard applicator, plastic
applicator, digital tampon, and others.
Based on size, the organic and
natural tampons market is segmented into junior tampons, regular tampons, super
tampons, and super-plus tampons. The regular tampons segment is expected to
account for the largest share segment of the market in 2023, as it was the
largest segment in 2017 and is likely to experience steady growth over the
forecast period. The majority of women prefer regular tampons, leading to a
growing demand for the segment.
Based on odor type, the organic
and natural tampons market is segmented into fragrance based and non-fragrance
based. The non-fragrance-based segment is expected to account for the largest
share segment of the market in 2017. Fragrance-based tampons are a relatively
novel part of the organic and natural tampons market and are likely to be a
major segment in the long-term future. However, in the short to medium term,
conventional non-fragrance-based tampons are likely to dominate the global organic
and natural tampons market.
Regional Analysis:
The Americas is expected to
dominate the global organic and natural tampons market over the forecast
period, while Asia Pacific is expected to be the fastest growing regional market
over the forecast period. The growing number of working women in North America
is the major driver for the organic and natural tampons market in the region.
The high market volume in Asia Pacific is likely to make it an important
regional market for organic and natural tampons over the forecast period.
Access full report @ https://www.marketresearchfuture.com/reports/organic-and-natural-tampons-market-7232
Get More Related
Report
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Virtual clinical trials are method of conducting clinical research using apps, electronically monitoring devices and online social engagement platforms. In 2020, 76% of more than 200 clinical trial sponsors said they conducted most or all of their patient monitoring remotely, up from only 18% of respondents the previous year, according to the 2021 State of the Industry Report from Florence Healthcare (US), a provider of digital research workflows and remote site access. This exponential increase in number of clinical trials monitored digitally is expected to increase the growth of global virtual clinical trials market during the forecast period.
The global virtual clinical trials market size is currently dominated by several market players. The key players are involved in geographic expansion, acquisition, and strategic collaborations to maintain their global footprint in the global virtual clinical trials market. For instance, in June 2020, Tabula Rasa HealthCare (US), a New Jersey-based company collaborated with Washington-based health plan provider Regence (US) to virtually trial several different COVID-19 drug candidates and assess the risk of adverse drug events. Regence will provide de-identified medical information from about 500,000 of its members to Tabula Rasa HealthCare. Thus, an increasing number of healthcare companies collaborating with technology companies to leverage data-driven clinical studies for development of effective medication by monitoring trials remotely is increasing global virtual clinical trials market size. The demand created by pandemic for adoption of monitoring trials remotely is expected to increase the lucrativeness of virtual clinical trials market during the forecast period.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/10734
Key Players:
Segmentation
The global virtual clinical trials market has been segmented based on study type, phase, and indication.
The market, based on study type, has been divided into interventional, observational and others. The interventional segment is likely to hold maximum market share in the global virtual clinical trials market owing to its larger utility and recruitment of patients for testing novel drugs.
The virtual clinical trials market based on phase has been segmented into Phase 1, Phase 2, Phase 3 and Phase 4. The Phase 1 segment is likely to hold significant share in the market as every clinical trial study proceeds through Phase 1.
The virtual clinical trials market based on indication has been segmented into oncology, cardiovascular, immunology, gastrointestinal, respiratory, endocrinology, ophthalmology and others. The oncology segment is likely to hold the largest share in the market due to larger number of clinical trials focused on finding treatment options for cancer.
Regional Analysis
The market has been divided, by region, into the North America, Europe, Asia-Pacific, and Rest of the World.
North America is anticipated to hold the largest market share owing to availability of major players operating in the region. Medable, Inc. (US), Oracle Corporation (US), IQVIA Holdings, Inc. (US), Syneos Health (US), PPD, Inc. (US) and Medpace Holdings, Inc. (US) are some of the notable companies operating in the region. Moreover, collaborative approach by companies operating in the region were observed due to rising demand and continuation of early phase clinical studying during the pandemic. For instance, during October 2020, FHI Clinical Inc. (US), a contract research organization adopted Oracle’s (US) Oracle Health Sciences Clinical One, a cloud platform for effective study management throughout the entire drug development lifecycle. FHI clinical also uses Oracle Argus Safety for safety case management; Oracle Clinical Trial Management System Cloud Service to manage the research portfolio; and Oracle ClearTrial Cloud Service to manage projects. Thus, increasing adoption of cloud-based platforms by contract research organizations operating in the region are anticipated to fuel the growth of virtual clinical trials market. The virtual clinical trials market in North America is divided into the US and Canada.
European virtual clinical trials market has been categorized into Germany, France, the UK, Italy, Spain, and the rest of Europe. Europe is anticipated to hold the significant market share owing to investment activities related to clinical trials in the region and support from government for R&D. For example, Parexel International Corporation (US) in November 2020 announced a strategic partnership between its Early Phase Clinical Unit (Germany) and Clinical Trial Center (CTC) North, a full-service CRO located at the University Medical Center Hamburg-Eppendorf (Germany). Parexel intends to roll-out and implement eSource system ClinBase at CTC North to drive efficiency. An increasing number of research institutes partnering with leading clinical trial services provider to accelerate development of products for different conditions such as cancer, COVID-19 and other disorders is expected to fuel growth of virtual clinical trials market during the forecast period. Moreover, ongoing research studies being converted to virtual mode are expected to increase the demand for IT services, thereby generating opportunities for IT companies to access virtual clinical trials market. Thus, long-term partnerships among research institutes and service providers to accelerate ongoing research studies is anticipated to increase the lucrativeness of virtual clinical trials market in the region during the forecast period.
The virtual clinical trials market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The growth of virtual clinical trials market in Asia-Pacific is anticipated to witness rapid growth during the forecast period owing to increasing number of memorandum signed by governmental agencies to promote research activities. For example, India and the UK announced a new memorandum of understanding in November 2020 between the Central Drugs Standard Control Organisation (India) and the UK Medicines and Healthcare Products Regulatory Agency. This memorandum is expected to increase bilateral regulations, sharing of information to control the trade of unlicensed products and 10-year roadmap for bilateral cooperation on the COVID-19 vaccine. Moreover, during April 2020 the Chinese government issued a plan of action in order to promote virtual clinical trials. Apart from support from governmental agencies to promote decentralized clinical trials, pharmaceutical companies operating in the Asia-Pacific are adopting to report clinical trials data virtually.
Access full report @ https://www.marketresearchfuture.com/reports/virtual-clinical-trials-market-10734
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Highlights
According to MRFR analysis, the global low-pressure liquid chromatography market is expected to register a CAGR of ~3.6% from 2020 to 2027.
The global low-pressure liquid chromatography market is driven by the expansion of research facilities across the globe, increasing government funding in the healthcare sector, and the rising population diagnosed with hereditary disorders such as Parkinson's disease, sickle cell disease, and Alzheimer's disease. In addition, increasing demand for DNA-based, RNA-based, and protein-based medicines to treat hereditary problems has created opportunities for the market players. Additionally, the low-pressure liquid chromatography systems segregate proteins, nucleic acids, and other small & complex molecules involved in several biological procedures. Moreover, the low-pressure liquid chromatography is also utilized to separate two polar organic solutes, screen drugs in sports, and segregate a wide range of hypersensitive and nonsteroidal anti-inflammatory drugs. The rise in the adoption of such biological extraction methodologies is expected to augment the low-pressure liquid chromatography market share.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/10724
Key Players
Some of the key players in the global low-pressure liquid chromatography market are Novasep (France), LEWA GmbH (Germany), GALAK Chromatography Technology Co., Ltd (China), Biolinx Labsystems (India), and Bio-Rad Laboratories, Inc. (US).
Segmentation
The global low-pressure liquid chromatography market is segmented into components and end user. Based on component, the market has been segregated into instruments, consumables, and services. The instruments segment held a considerable market share in 2020. The demand for low-pressure liquid chromatography is the largest contributor to the global market due to its high engagement in research facilities to derive COVID-19 vaccines and other microbial infection treatments. In addition, the ongoing innovation of drugs and treatment for chronic diseases are strengthening the demand for low-pressure liquid chromatography products.
Based on end user, the global low-pressure liquid chromatography market has been classified as pharmaceutical companies, biotechnology companies, research laboratories, and academic institutions. Pharmaceutical companies held a considerable share of the market in 2020, owing to the high demand for medicines across the globe due to the spread of deadly coronavirus and chronic diseases. Additionally, increasing public and private investments in drug development and growing funding in the pharmaceutical sector to transform the research and production facilities are expected to drive the segment in the projected timeline.
The industry providers are involved in technological enhancement, product development, expansion of distribution network, investment public relations, and mergers & acquisitions to expand their global footprint. The industry players are planning to adopt business plans such as the development of advanced low-pressure liquid chromatography systems to provide accurate and efficient test and extraction results. Additionally, the global market players aim to invest in the developing countries owing to supportive government policies, economic labor costs, and the high availability of raw materials. These factors will strengthen the market development and will propel the market demand in the projected period.
Regional Analysis
North America is projected to dominate the low-pressure liquid chromatography market in the forecast period, owing to the presence of a large number of market players, increasing government fundings, expansion in research facilities, extensive distribution network, and growing usage of chromatography in drug development. Furthermore, the key players are involved in business approaches such as collaborations, mergers, technical partnerships, government alliances, and an increasing number of clinical trials are a few of the factors propelling the market growth. Europe embraces the second-largest position in the low-pressure liquid chromatography market due to the increasing development, manufacturing, and commercialization of therapeutics, increasing establishment of analytical and biotechnology laboratories across the region. Likewise, increasing the utilization of molecular diagnosis for forensic investigation is driving the European low-pressure liquid chromatography market. The industry players provide high-quality products and superior after-sales service to gain an edge over the existing industry providers. These business parameters are expected to propel the low-pressure liquid chromatography market in the anticipated time.
Asia-Pacific is likely to hold the major market share over the assessed timeline due to the transformation in pharmaceutical infrastructure, high investment in the modernization of research laboratories, rising demand for generic and advanced medicines across the region, and increasing awareness about genetic and molecular drugs. Moreover, the rising demand for environmental and chemical analysis devices and equipment is driving the Asia-Pacific low-pressure liquid chromatography market.
Access full report @ https://www.marketresearchfuture.com/reports/low-pressure-liquid-chromatography-market-10724
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Nitrile rubber is more resistant to oils, chemicals, and acids than natural rubber and has greater strength. Gloves made from latex are less puncture-resistant as compared to nitrile gloves. Similarly, gloves made from vinyl are less chemical resistant as compared to nitrile gloves. Nitrile is now the choice material for manufacturing disposable mechanics gloves and other industrial-grade gloves that are used in risky work environments where all kinds of sharp objects are in use.
The global disposable nitrile gloves market Size is growing steadily. Factors that influence the disposable nitrile gloves market are increasing preference for use at workplaces across several industries and growing awareness on prevention of healthcare-associated infection (HAI).
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/10675
Ansell (US), Medline Industries (US), Paul Hartmann (Germany),Polyco Healthline (UK),andAurelia Gloves(UK) are the key market players.
Segment Analysis
Based on type, the market isbifurcated into powder-freeand powdered. The powder-free segment dominated the market in 2020 and is projected to be a faster-growing segment during the forecast period.This is attributed to thehigh strength and durability powder-free disposable nitrile gloves, making them useful for manufacturing industries where workers may encounter materials made of glass and metal.
Based on application,the global disposable nitrile gloves market is segmented into medical and non-medical. The medical segment dominated the market in 2020 and is projected to record a faster growth rate during the forecast period.The disposable nitrile gloves are used in healthcare facilities primarily for examining patients and are worn by healthcare workers and sometimes patients as well.
Regional Analysis
Based on region, the market is studied acrossthe Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas accounted for the largest market share in 2020 and is anticipated to dominate the global disposable nitrile gloves market during the forecast period. However, Asia-Pacific is projected to register the highest CAGR during the forecast period.
The Americas is expected to dominate with the largest market share due to a well-developed healthcare sector, high imports of disposable nitrile gloves, and the increasing number of healthcare-related infections over the past decade. In the region, modern healthcare employs various types of invasive procedures and devices to treat patients and facilitate their recovery process. Healthcare-related infections in the region are commonly associated with devices such as catheters, ventilators, and surgical operations. The market in the Americas has been divided into North America and Latin America.The market in North America has been divided further into the US and Canada. The US accounts for the largest market share in the North American disposable nitrile gloves market. In the US, the Centers for Disease Control and Prevention (CDC) has been working to monitor and prevent such hospital-related infections, as they pose serious health concerns.The availability of government regulations regarding imports of essential goods and a large volume of imports are the drivers for the disposable nitrile gloves market in the region.For instance, an increase of 35.7% was observed in the import of medical gloves in Canada in May 2020 compared to April 2020. A considerable portion of demand for disposable nitrile gloves is expected to come from new industries that are emphasizing implementing policies for wearing disposable gloves for grocery clerks and e-commerce packing & delivery staff.
Europe is the second-largest market for disposable nitrile gloves. The growing demand for disposable nitrile gloves in Europeis attributed to the increasing utility of disposable nitrile gloves across major industries, including healthcare, pesticide, petrochemical & auto motive, government initiatives towards promoting safer work conditions, and more eco-friendly nitrile gloves. The increasing prevalence of healthcare-associated infections in European countries is also one of the major factors responsible for the rising demand for disposable nitrile gloves in the region. According to the European Centre for Disease Prevention and Control, the average prevalence of hospital-acquired infections is estimated to be 7.1% in European countries.
Access full report @ https://www.marketresearchfuture.com/reports/disposable-nitrile-gloves-market-10675
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Highlights
According to MRFR analysis, the global Real-Time PCR (Qpcr)
Market is expected to register a CAGR of ~8.92 from 2021 to 2027 and hold a
value of ~USD 8,398.55 million by 2027.
The global real-time PCR (qPCR) market is driven by
continued efforts by PCR manufacturers to develop novel kits and systems to be
used in molecular diagnostic testing. For example, in January 2019, Qiagen
N.V.(Germany) developed next-generation qPCR systems, which were launched in
April 2020. The new system isprojected to offer highly automated workflowand
quick turnaround time. This factor is likely to provide a significant
competitive advantage to the company, fueling the overall Real-Time
PCR (qPCR)market Size
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/10672
Key Players
Some of the key players in the global real-time PCR
(qPCR)marketareABL SA Group (Luxembourg), Agilent Technologies, Inc. (US),
Analytik Jena AG (Germany), BD (US), Bio-Rad Laboratories, Inc. (US), F.
Hoffmann-La Roche Ltd (Switzerland), Fluidigm Corporation (US), Lumex
Instruments (US), Primerdesign Ltd (UK), QIAGEN (Germany), Takara Bio Inc.
(Japan), Thermo Fisher Scientific (US), TOYOBO Inc. (Japan), and Vela
Diagnostics (Singapore).
Severalglobal and local market players dominate the global
real-time PCR (qPCR) market, contributing to a substantial market share. The
prominent players are engaged in organic and inorganic strategies such
asagreements, new product development & launches, and approval from
government authorities, joint ventures, mergers & acquisitions, and
partnerships to sustaintheir market positions.For instance, in October 2017,
AOAC International (US), independent standards developing organization
certified Bio-Rad Laboratories (US) iQ-Check Real-time PCR (qPCR) Kit as the
Official Method of Analysis for Salmonella species identification in raw meat.
Such recognition to the company is anticipated to boost the market growth.
Segmentation
By product, the market has been segregated into reagents
& consumables, instruments, and software & services. The reagents &
consumables segment is expected to hold a considerable share of the market in
2021. Increasing adoption of reagents and consumables
Based on application,the real-time PCR (qPCR)market is
classified into clinical, research, forensics, and others. The clinical segment
held the largest market share in 2020. Some of the key factors attributing to
the market growth include the increasing adoption of Real-time PCR (qPCR) to
diagnose and estimate disease-causing microbes and other clinical ailments.
On the basis of the end user,the real-time PCR (qPCR) market
is segmented into hospitals & diagnostic centers, research laboratories
& academic institutes, pharmaceutical & biotechnology companies,
clinical research organizations, and forensic laboratories. The research laboratories
& academic institutes segment accounted for the major share in 2020 among
the end user segment of the global real-time PCR (qPCR) market due tothe
increasing number of research laboratories and rising application of Real-time
PCR (qPCR) in sectors such as stem cell research and genetic disease and
oncology research.
Regional Analysis
Based on region, North America is expectedto dominate the global real-time PCR
(qPCR) market in 2020 due to the rising adoption of novel and innovative
genomic analysis products and the availability of R&D grants.
The high prevalence of chronic & infectious diseases
coupled with increasing awareness among patients about early diagnosis of
diseases is propelling the market growth.
Europe is expected to hold the second-largest position in
the global real-time PCR (qPCR) market in 2021. Key factors attributing to the
market growth are increasing adoption of real-time PCR (qPCR) to diagnose and
estimate disease-causing microbes, with increasing product availability
forconsumers.
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/real-time-pcr-qpcr-market-10672
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America